Search Medical Condition
Please enter condition
Please choose location from dropdown

One Or Multiple Investigational Sites, Japan Clinical Trials

A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (57291) clinical trials

This multicenter, randomized, double-blind, placebo controlled, parallel group study is being conducted to provide data on efficacy, safety, tolerability and pharmacokinetics (PK) of multiple dose levels of PF-06882961 in adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin and/or diet and exercise. In addition, the study is intended …

Phase

The goal of this research study is to understand the evolution of levodopa-induced dyskinesias (LID), a refractory and disabling side effect of the gold standard treatment of Parkinson's disease, in hopes of identifying information that can help slow or prevent the development of LID in future patients.  

Phase N/A

Patients eligible for enrollment in this study will be from the Northwell Neurosurgery practice. We propose to enroll an initial set of 10 BAVM patients and 10 epilepsy patients in the first year.  After this time, assessment will be made to determine the additional number of patients to be enrolled. We …

Phase N/A

The primary objective is to determine if BIIB093 improves functional outcome at Day 90 as measured by the modified Rankin Scale (mRS) when compared with placebo in participants with Large Hemispheric Infarction (LHI). The secondary objectives are to determine if BIIB093 improves overall survival at Day 90 when compared with …

Phase

The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following aneurysmal subarachnoid hemorrhage.  

Phase

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.  

Phase

CURRENTLY ENROLLING! Meningococcal Vaccine Study Study at ClinSearch Meningococcal disease is caused by a germ. There are many different types of this germ. This study will explore an investigational vaccine that might help defend the body against different types of germs that cause meningococcal disease. The purpose of this study …

Phase N/A